Skip to main content
SpringerLink
Log in

Selenium and immunocompetence in patients with head and neck cancer

  • Accelerated Article
  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

This randomized double-blind placebo-controlled study aimed to determine whether oral intake of 200 µg/d of sodium selenite, a dose within the safe and adequate daily intake (50–200 µg/d) recommended by the U.S. Food and Nutrition Board, will abrogate depressed or enhance normal-level immune functions of patients receiving therapy for squamous cell carcinoma of the head and neck. Subjects were given one selenium/placebo tablet/d for 8 wk, beginning on the day of their first treatment for the disease (e.g., surgery, radiation, or surgery and radiation) and their immune functions were monitored. Supplementation with selenium (Se) during therapy resulted in a significantly enhanced cell-mediated immune responsiveness, as reflected in the ability of the patient’s lymphocytes to respond to stimulation with mitogen, to generate cytotoxic lymphocytes, and to destroy tumor cells. The enhanced responsiveness was evident during therapy and following conclusion of therapy. In contrast, patients in the placebo arm of the study showed a decline in immune responsiveness during therapy, which was followed, in some patients, by an enhancement, but the responses of the group remained significantly lower than baseline values. The data also show that at baseline, patients entered in the study had significantly lower plasma Se levels than healthy individuals, and patients in stage I or II of disease had significantly higher plasma selenium levels than patients in stage III or IV of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cancer Statistics 1999, CA: A Cancer J. Clinicians (January 1999).

  2. Cancer Facts and Figures for Minority Americans, 1991, American Cancer Society, Atlanta, GA, pp. 9–10 (1991).

  3. E. Y. Hilal, H. J. Wanebo, C. M. Pinsky, P. Middleman, E. W. Strong, and H. F. Oettgen, Immunologic evaluation and prognosis in patients with head and neck cancer, Am. J. Surg. 134, 469–473 (1977).

    Article  Google Scholar 

  4. M. J. Deegan, W. S. Coulthard, S. J. Qualman, and M. A. Shork, A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck, Cancer Res. 37, 4475–4481 (1977).

    PubMed  CAS  Google Scholar 

  5. R. O. Gustafson, H. B. Neel III, and G. R. Pearson, Immunologic studies on cancer of the upper aerodigestive tract, Otolaryngol. Head Neck Surg. 90, 52–57 (1982).

    PubMed  CAS  Google Scholar 

  6. R. Roubin, F. Bekkoucha, and M. C. Fondaneche, Lymphoid cells in lymph nodes and peripheral blood of patients with squamous cell carcinoma of head and neck, J. Cancer Res. Clin. Oncol. 102, 277–287 (1982).

    Article  PubMed  CAS  Google Scholar 

  7. T. Watanabe, J. D. Iglehart, and D. P. Bolognesi, Secretory immune response in patients with oropharyngeal carcinoma, Ann. Otol. Rhinol. Laryngol. 92, 295–299 (1983).

    PubMed  CAS  Google Scholar 

  8. P. L. Twomey, W. J. Catalona, and P. B. Chretien, Cellular immunity in cured cancer patients, Cancer 33, 435–440 (1974).

    Article  PubMed  CAS  Google Scholar 

  9. J. Zighelboim, F. Dorey, V. H. Parker, J. Calceterra, P. Ward, and J. L. Fahey, Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunetherapy, Cancer 44, 117–123 (1979).

    Article  PubMed  CAS  Google Scholar 

  10. D. P. Eskinazi, Y. Helman, A. G. Ershow, J. J. Perna, and R. Mihail, Nonspecific immunity and head and neck cancer: blastogenesis reviewed and revisited, Oral Surg. 60, 642–647 (1985).

    Article  PubMed  CAS  Google Scholar 

  11. J. Lundy, H. Wanebo, C. Pinsky, E. Strong, and H. Oettgen, Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck, Am. J. Surg. 128, 530–533 (1974).

    Article  PubMed  CAS  Google Scholar 

  12. S. P. Schantz and H. G. Goepfert, Multimodality therapy and distant metastases: the impact of natural killer cell activity, Arch. Otolarngol. Head Neck Surg. 113, 1207–1213 (1987).

    CAS  Google Scholar 

  13. S. P. Schantz and N. Ordonez, Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer, Natl. Immun. Cell Growth Regul. 10, 278–288 (1991).

    CAS  Google Scholar 

  14. S. P. Schantz, B. W. Brown, E. Lira, D. L. Taylor, and N. Beddingfield, Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer, Cancer Immunol. Immunother. 25, 141–148 (1987).

    Article  PubMed  CAS  Google Scholar 

  15. C. A. Perez, Effects of irradiation and chemotherapy in the immune response and potential investigations in patients with head and neck cancer, Laryngoscope 88, 1–9 (1978).

    Google Scholar 

  16. Z. L. Orlowski and S. A. Wilkins, T-lymphocyte levels in the peripheral blood of patients with cancer of the head and neck, Am. J. Surg. 130, 440–444 (1975).

    Article  Google Scholar 

  17. R. E. Pollock, E. Lotzova, and S. D. Stanford, Surgical stress impaires natural killer cell programming of tumor lysis in patients with sarcomas in other solid tumors, Cancer 70, 2192–2202 (1992).

    Article  PubMed  CAS  Google Scholar 

  18. M. Roy, L. Kiremidjian-Schumacher, H. I. Wish, M. W. Cohen, and G. Stotzky, Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression, Biol. Trace Element Res. 41, 103–114 (1994).

    CAS  Google Scholar 

  19. L. Kiremidjian-Schumacher, M. Roy, H. I. Wish, M. W. Cohen, and G. Stotzky, Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocyes and natural killer cells, Biol. Trace Element Res. 41, 115–127 (1994).

    Article  CAS  Google Scholar 

  20. C. B. Begg and B. Iglewicz, A treatment allocation procedure for sequential clinical trials, Biometrics 36, 81–90 (1980).

    Article  PubMed  CAS  Google Scholar 

  21. Committee on Dietary Allowances, Food and Nutrition Board, National Research Council, Recommended Dietary Allowances, 9th ed., National Academy Press, Washington, DC, 1980.

    Google Scholar 

  22. M. Janghorbani, R. F. Martin, L. J. Kasper, X. F. Sun, and V. R. Young, The selenite-exchangeable metabolic pool in humans: a new concept for the assessment of selenium status, Am. J. Clin. Nutr. 51, 670–677 (1990).

    PubMed  CAS  Google Scholar 

  23. M. Roy, L. Kiremidjian-Schumacher, H. I. Wish, M. W. Cohen, and G. Stotzky, Supplementation with selenium and immune cell function II. Effects on lymphocytemediated cytotoxicit, Proc. Soc. Exp. Biol. Med. 193, 143–148 (1990).

    PubMed  CAS  Google Scholar 

  24. B. E. Jacobson and G. Lockitch, Direct determination of selenium in serum by graphite furnace atomic absorption spectrometry with deuterium background correction and a reduced palladium modifier: age specific reference ranges, Clin. Chem. 34, 15–30 (1988).

    Google Scholar 

  25. H. J. Wanebo, D. Blackinton, and N. Kouttab, Contribution of serum inhibitory factors and immune cellular defects to depressed cell-mediated in patients with head and neck cancer, Am. J. Surg. 166, 389–394 (1993).

    Article  PubMed  CAS  Google Scholar 

  26. H. E. Katz, Update on immunology of head and neck cancer, Med. Clin. North Am. 77, 625–631 (1993).

    PubMed  CAS  Google Scholar 

  27. B. Phillips, M. E. Marshall, S. Brown, and J. S. Thompson, Effect of smoking on human natural killer cell activity, Cancer 56, 2789–2792 (1985).

    Article  PubMed  CAS  Google Scholar 

  28. G. J. Hauser, M. M. Chan, and W. F. Casey, Immune dysfunction in children after corrective surgery for congenital heart disease, Crit. Care Med. 19, 874–881 (1991).

    Article  PubMed  CAS  Google Scholar 

  29. M. S. Slade, R. L. Simmons, and E. Yunis, Immunodepression after major surgery in normal patients, Surgery 78, 363–372 (1975).

    PubMed  CAS  Google Scholar 

  30. J. L. Tarpley, C. Potvin, and P. B. Chretien, Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy, Cancer 35, 638.

  31. M. Roy, L. Kiremidjian-Schumacher, H. I. Wishe, M. W. Cohen, and G. Stotzky, Effect of selenium on the expression of high affinity interleukin-2 receptors, Proc. Soc. Exp. Biol. Med. 200, 36–46 (1992).

    PubMed  CAS  Google Scholar 

  32. M. Roy, L. Kiremidjian-Schumacher, H. I. Wishe, M. W. Cohen, and G. Stotzky, Effect of selenium supplementation on the IL2 receptor subunit expression and IL2 internalization, Proc. Exp. Biol. Med. 202, 295–301 (1993).

    CAS  Google Scholar 

  33. L. Kiremidjian-Schumacher, M. Roy, H. I. Wishe, M. W. Cohen, and G. Stotzky, Regulation of cellular immune responses by selenium, Biol. Trace Element Res. 33, 23–35 (1992).

    CAS  Google Scholar 

  34. W. J. Goodwin, H. W. Lane, K. Bradford, M. V. Marshall, C. Griffin, H. Geopfert, et al., Selenium and glutathione peroxidase levels in patients with epidermoid carcinoma of the oral cavity and oropharynx, Cancer 51, 110–115 (1983).

    Article  PubMed  Google Scholar 

  35. W. L. Broghamer, Jr., K. P. McConnell, and A. L. Blotcky, Relationship between serum selenium levels and patients with carcinoma, Cancer 37, 1384–1388 (1976).

    Article  PubMed  CAS  Google Scholar 

  36. L. Kiremidjian-Schumacher and G. Stotzky, Selenium and immune responses. A review, Environ. Res. 42, 277–303 (1987).

    Article  PubMed  CAS  Google Scholar 

  37. W. C. Willet, B. V. Polk, J. S., Morris, M. J. Stampler, S. Pressie, B. Rosner, et al., Prediagnostic serum selenium and risk of cancer, Lancet 2, 130–134 (1983).

    Article  Google Scholar 

  38. G. N. Schrauzer, D. A. White, and C. J. Schneider, Cancer mortality correlation studies IV: Associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists, Bioinorg. Chem. 7, 35–56 (1977).

    Article  PubMed  CAS  Google Scholar 

  39. G. F. Combs, Selenium and cancer prevention, in Antioxidants and Disease Prevention, H. Garewal, ed., CRC Press, Boca Raton, FL, pp. 97–105 (1997).

    Google Scholar 

  40. P. R. Harrison, J. Lanfear, L. Wu, J. Fleming, L. McGarry, and L. Blower, Chemopreventive and growth inhibitory effects of selenium, Biomed. Environ. Sci. 10, 235–245 (1997).

    PubMed  CAS  Google Scholar 

  41. G. N. Schrauzer, Selenium. Mechanistic aspects of anticarcinogenic action, Biol. Trace Element Res. 33, 51–62 (1992).

    CAS  Google Scholar 

  42. F. R. Khuri, S. M. Lippman, M. R. Spitz, and R. Lotan, Molecular epidemiology and retinoid chemoprevention of head and neck cancer, J. Natl. Cancer Inst. 89, 199–211 (1997).

    Article  PubMed  CAS  Google Scholar 

  43. L. C. Clark, G. F. Combs, B. W. Turmbull, E. H. Slate, D. Alberts, D. Abele, et al., Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin, J. Am. Med. Assoc. 276, 1957–1963 (1996).

    Article  CAS  Google Scholar 

  44. G. F. Combs, L. C. Clark, and B. W. Turnbull, Reduction of cancer risk with oral supplement of selenium, Biomed. Environ. Sci. 10, 227–234 (1997).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Basic Sciences, New York University Dental Center, 345 East 24th Street, 10010, New York, NY

    L. Kiremidjian-Schumacher, M. Roy & R. Glickman

  2. New York University Medical Center, 10016, New York, NY

    K. Schneider, S. Rothstein, J. Cooper, H. Hochster & M. Kim

  3. Harlem Hospital Center, 10037, New York, NY

    R. Newman

Authors
  1. L. Kiremidjian-Schumacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Glickman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Rothstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Hochster
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R. Newman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiremidjian-Schumacher, L., Roy, M., Glickman, R. et al. Selenium and immunocompetence in patients with head and neck cancer. Biol Trace Elem Res 73, 97–111 (2000). https://doi.org/10.1385/BTER:73:2:97

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/BTER:73:2:97

Index Entries

Search

Navigation